Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of pioglitazone on renal transplant function in diabetics
2006-004467-65Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in diabetic glomerulosclerosis, Transplant Nephropathy and type 2 diabetes mellitus (T2DM), sponsored by Technische Universität Dresden. Primary endpoint: Proteinuria. Started Oct 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
diabetic glomerulosclerosisTransplant Nephropathytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-004467-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004467-65.